IKARAN

This brand name is authorized in Tunisia

Active ingredients

The drug IKARAN contains one active pharmaceutical ingredient (API):

1 Dihydroergotamine
UNII 436O5HM03C - DIHYDROERGOTAMINE

Dihydroergotamine binds with high affinity to 5-HT1Dฮฑ and 5-HT1Dฮฒ receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors. The therapeutic activity of dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Read about Dihydroergotamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CA01 Dihydroergotamine N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CA Ergot alkaloids
Discover more medicines within N02CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 6063013, 9323051

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈